222 related articles for article (PubMed ID: 15798395)
1. Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen.
Sorota S; Zhang XS; Margulis M; Tucker K; Priestley T
Assay Drug Dev Technol; 2005 Feb; 3(1):47-57. PubMed ID: 15798395
[TBL] [Abstract][Full Text] [Related]
2. Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.
Bridgland-Taylor MH; Hargreaves AC; Easter A; Orme A; Henthorn DC; Ding M; Davis AM; Small BG; Heapy CG; Abi-Gerges N; Persson F; Jacobson I; Sullivan M; Albertson N; Hammond TG; Sullivan E; Valentin JP; Pollard CE
J Pharmacol Toxicol Methods; 2006; 54(2):189-99. PubMed ID: 16563806
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human Ether-à-go-go related gene screening assays based on IonWorks Quattro and thallium flux.
Bridal TR; Margulis M; Wang X; Donio M; Sorota S
Assay Drug Dev Technol; 2010 Dec; 8(6):755-65. PubMed ID: 20658944
[TBL] [Abstract][Full Text] [Related]
4. Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.
Gillie DJ; Novick SJ; Donovan BT; Payne LA; Townsend C
J Pharmacol Toxicol Methods; 2013; 67(1):33-44. PubMed ID: 23103595
[TBL] [Abstract][Full Text] [Related]
5. Characterization of potassium channel modulators with QPatch automated patch-clamp technology: system characteristics and performance.
Kutchinsky J; Friis S; Asmild M; Taboryski R; Pedersen S; Vestergaard RK; Jacobsen RB; Krzywkowski K; Schrøder RL; Ljungstrøm T; Hélix N; Sørensen CB; Bech M; Willumsen NJ
Assay Drug Dev Technol; 2003 Oct; 1(5):685-93. PubMed ID: 15090241
[TBL] [Abstract][Full Text] [Related]
6. Halide ion effects on human Ether-à-go-go related gene potassium channel properties.
Zeng H; Balasubramanian B; Penniman JR; Kinose F; Salata JJ; Lagrutta A
Assay Drug Dev Technol; 2013; 11(9-10):544-50. PubMed ID: 24147984
[TBL] [Abstract][Full Text] [Related]
7. Rb+ flux through hERG channels affects the potency of channel blocking drugs: correlation with data obtained using a high-throughput Rb+ efflux assay.
Rezazadeh S; Hesketh JC; Fedida D
J Biomol Screen; 2004 Oct; 9(7):588-97. PubMed ID: 15475478
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological analysis of mammalian cells expressing hERG using automated 384-well-patch-clamp.
Haraguchi Y; Ohtsuki A; Oka T; Shimizu T
BMC Pharmacol Toxicol; 2015 Dec; 16():39. PubMed ID: 26671227
[TBL] [Abstract][Full Text] [Related]
9. Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks.
Harmer AR; Abi-Gerges N; Easter A; Woods A; Lawrence CL; Small BG; Valentin JP; Pollard CE
J Pharmacol Toxicol Methods; 2008; 57(1):30-41. PubMed ID: 17980627
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of high throughput functional assay methods for HERG potassium channel.
Tang W; Kang J; Wu X; Rampe D; Wang L; Shen H; Li Z; Dunnington D; Garyantes T
J Biomol Screen; 2001 Oct; 6(5):325-31. PubMed ID: 11689132
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the rubidium efflux assay for preclinical identification of HERG blockade.
Chaudhary KW; O'Neal JM; Mo ZL; Fermini B; Gallavan RH; Bahinski A
Assay Drug Dev Technol; 2006 Feb; 4(1):73-82. PubMed ID: 16506891
[TBL] [Abstract][Full Text] [Related]
12. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
[TBL] [Abstract][Full Text] [Related]
13. Modulation of HERG channel inactivation by external cations.
Youm JB; Earm YE; Ho WK
Eur Biophys J; 2004 Jul; 33(4):360-9. PubMed ID: 14586519
[TBL] [Abstract][Full Text] [Related]
14. IonFlux: a microfluidic patch clamp system evaluated with human Ether-à-go-go related gene channel physiology and pharmacology.
Golden AP; Li N; Chen Q; Lee T; Nevill T; Cao X; Johnson J; Erdemli G; Ionescu-Zanetti C; Urban L; Holmqvist M
Assay Drug Dev Technol; 2011 Dec; 9(6):608-19. PubMed ID: 21561375
[TBL] [Abstract][Full Text] [Related]
15. Validation of a medium-throughput electrophysiological assay for KCNQ2/3 channel enhancers using IonWorks HT.
Jow F; Shen R; Chanda P; Tseng E; Zhang H; Kennedy J; Dunlop J; Bowlby MR
J Biomol Screen; 2007 Dec; 12(8):1059-67. PubMed ID: 18087070
[TBL] [Abstract][Full Text] [Related]
16. High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656.
Ridley JM; Milnes JT; Witchel HJ; Hancox JC
Biochem Biophys Res Commun; 2004 Dec; 325(3):883-91. PubMed ID: 15541373
[TBL] [Abstract][Full Text] [Related]
17. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.
Schmalhofer WA; Swensen AM; Thomas BS; Felix JP; Haedo RJ; Solly K; Kiss L; Kaczorowski GJ; Garcia ML
Assay Drug Dev Technol; 2010 Dec; 8(6):714-26. PubMed ID: 21158686
[TBL] [Abstract][Full Text] [Related]
18. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization.
Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P
Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128
[TBL] [Abstract][Full Text] [Related]
19. hERG potency estimates based upon dose solution analysis: What have we learned?
Qu Y; Schnier P; Zanon R; Vargas HM
J Pharmacol Toxicol Methods; 2011; 64(3):251-7. PubMed ID: 21888984
[TBL] [Abstract][Full Text] [Related]
20. hERG drug response measured in droplet bilayers.
Portonovo SA; Salazar CS; Schmidt JJ
Biomed Microdevices; 2013 Apr; 15(2):255-9. PubMed ID: 23160842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
